TABLE 4.
Current medications prescribed to patients with chronic obstructive pulmonary disease (COPD) according to disease severity determined by Medical Research Council (MRC) dyspnea score
| Current medication |
COPD severity according to MRC dyspnea score
|
|||
|---|---|---|---|---|
| MRC 1 (n=50) | Mild (MRC 2) (n=220) | Moderate (MRC 3–4) (n=582) | Severe (MRC 5) (n=79) | |
| Salbutamol (SABA) | 66 | 74 | 78 | 81 |
| Terbutaline (SABA) | 0 | 3 | 3 | 1 |
| Ipratropium (SAAC) | 12 | 11 | 12 | 8 |
| Tiotropium (LAAC) | 34 | 65 | 76 | 95 |
| Salmeterol (LABA) | 2 | 1 | 4 | 2 |
| Budesonide/formoterol (ICS/LABA) | 24 | 22 | 25 | 24 |
| Fluticasone/salmeterol (ICS/LABA) | 26 | 49 | 53 | 72 |
| Theophylline | 2 | 2 | 9 | 21 |
| Chronic antibiotics | 2 | 1 | 1 | 2 |
| Oral steroids | 0 | 4 | 4 | 16 |
| Other | 6 | 7 | 12 | 21 |
| None | 10 | 5 | 2 | 0 |
Data presented as %. ICS Inhaled corticosteroid; LAAC Long-acting anticholinergic; LABA Long-acting beta2-agonist; SAAC Short-acting anticholinergic; SABA Short-acting beta2-agonist